CellaVision announces extraordinary general meeting on 2 September 2026
Shareholders will vote on a new employee option program for the CEO, including a directed issue of 100,000 warrants, at the meeting in Lund.
See the latest news and media coverage for CellaVision. We track all announcements, press releases, and industry mentions in real time, all in one place.
Digital hematology microscopy solutions provider
cellavision.comLast updated
In short: CellaVision reported record Q2 sales in the Americas, appointed Steve Ferguson as CEO, and launched its CE-marked Bone Marrow application.
Shareholders will vote on a new employee option program for the CEO, including a directed issue of 100,000 warrants, at the meeting in Lund.
Organic sales growth was 5.6%, EBITDA margin 27%, and CEO Steve Ferguson appointed.
He replaces Simon Østergaard and brings over 25 years of biotech experience.
It enables collaboration on analysis to share expertise and reduce variability. Available in CE-marked markets under EU IVDR; not FDA-approved.
Good morning, everyone, and thank you for joining us today. My name is Steve Ferguson, and with me is our Chief Financial Officer, Monica Jonsson...
Cellavision, which is active in systems for automatic image analysis of blood and other body fluids, reports an EBITDA result of 55 million kronor...
In today's recommendation flow, Cellavision has received a downgraded recommendation from Pareto to hold while the target price is raised. Among the other updates, ...
Detailed price information for Cellavision Ab Ord (CLVSF) from The Globe and Mail including charting and trades.
Track CellaVision and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to CellaVision and other trending companies.